BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11291572)

  • 1. [Invasive aspergillosis on a surgical intensive care unit].
    Kujath P; Klempien I; Muhl E; Kämmerer R
    Mycoses; 2000; 43 Suppl 2():23-7. PubMed ID: 11291572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
    Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
    Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
    Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
    N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
    Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
    Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of brain aspergillosis with voriconazole.
    Tattevin P; Bruneel F; Lellouche F; de Broucker T; Chevret S; Wolff M; Régnier B
    Clin Microbiol Infect; 2004 Oct; 10(10):928-31. PubMed ID: 15373890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
    Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
    Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    Sambatakou H; Dupont B; Lode H; Denning DW
    Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive aspergillosis of orbit in immunocompetent patients: treatment and outcome.
    Pushker N; Meel R; Kashyap S; Bajaj MS; Sen S
    Ophthalmology; 2011 Sep; 118(9):1886-91. PubMed ID: 21665281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aspergillus spondylodiscitis. Apropos of 5 cases].
    Cortet B; Deprez X; Triki R; Savage C; Flipo RM; Duquesnoy B; Delcambre B
    Rev Rhum Ed Fr; 1993 Jan; 60(1):37-44. PubMed ID: 8242025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive aspergillosis in a tertiary-care hospital in Thailand.
    Kiertiburanakul S; Thibbadee C; Santanirand P
    J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
    Wingard JR; Herbrecht R; Mauskopf J; Schlamm HT; Marciniak A; Roberts CS
    Transpl Infect Dis; 2007 Sep; 9(3):182-8. PubMed ID: 17605747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
    Chandrasekar PH; Cutright JL; Manavathu EK
    Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated invasive aspergillosis in an apparently immunocompetent host.
    Raja NS; Singh NN
    J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
    Mattei D; Mordini N; Lo Nigro C; Ghirardo D; Ferrua MT; Osenda M; Gallamini A; Bacigalupo A; Viscoli C
    Bone Marrow Transplant; 2002 Dec; 30(12):967-70. PubMed ID: 12476292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
    Wieland T; Liebold A; Jagiello M; Retzl G; Birnbaum DE
    J Heart Lung Transplant; 2005 Jan; 24(1):102-4. PubMed ID: 15653389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Curative treatment of invasive aspergillosis].
    Dupont B
    Pathol Biol (Paris); 1994 Sep; 42(7):688-93. PubMed ID: 7877863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Invasive aspergillosis in surgical intensive care patients].
    Blanloeil Y; François T; Germaud P; Le Conte P; Morin O; Michel P; Levron JC; Dixneuf B
    Ann Fr Anesth Reanim; 1993; 12(4):379-84. PubMed ID: 8273926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.
    Paterson PJ; Seaton S; Prentice HG; Kibbler CC
    J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant itraconazole in the treatment of destructive sphenoid aspergillosis.
    Rowe-Jones JM; Freedman AR
    Rhinology; 1994 Dec; 32(4):203-7. PubMed ID: 7701229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis.
    Chow L; Brown NE; Kunimoto D
    Clin Infect Dis; 2002 Nov; 35(9):e106-10. PubMed ID: 12384856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.